• Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study. Blood (2023) 142 (Supplement 1): 535.
  • New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. JAMA Oncol. 2025 May 29;11(7):753–761.
  • Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study. Blood Cancer J. 2022 Sep 14;12(9):133.